Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage

被引:154
作者
Hendriks, RW
deBruijn, MFTR
Maas, A
Dingjan, GM
Karis, A
Grosveld, F
机构
[1] ERASMUS UNIV ROTTERDAM, FAC MED, DEPT IMMUNOL, NL-3000 DR ROTTERDAM, NETHERLANDS
[2] LEIDEN UNIV HOSP, DEPT IMMUNOHAEMATOL, NL-2333 AA LEIDEN, NETHERLANDS
关键词
B cell development; Btk; immunodeficiency; XLA; xld;
D O I
10.1002/j.1460-2075.1996.tb00867.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bruton's tyrosine kinase (Btk) is a cytoplasmic protein kinase that is defective in X-linked agammaglobulinaemia in man and in X-linked immunodeficiency in the mouse. There is controversy regarding the stages of B cell development that are dependent on Btk function, To determine the point in B cell differentiation at which defects in Btk become apparent, we generated a mouse model by inactivating the Btk gene through an in-frame insertion of a lacZ reporter by homologous recombination in embryonic stem cells. The phenomenon of X-chromosome inactivation in Btk(+/-) heterozygous female mice enabled us to evaluate the competition between B cell progenitors expressing wildtype Btk and those expressing the Bfk(-)/lacZ allele in each successive step of development, Although Bfk was already expressed in pro-B cells, the first selective disadvantage only became apparent at the transition from small pre-B cells to immature B cells in the bone marrow, A second differentiation arrest was found during the maturation from IgD(low)IgM(high) to IgD(high)IgM(low) stages in the periphery, Our results show that Bfk expression is essential at two distinct differentiation steps, both past the pre-B cell stage.
引用
收藏
页码:4862 / 4872
页数:11
相关论文
共 60 条
  • [1] DEVELOPMENT OF THE PRIMARY ANTIBODY REPERTOIRE
    ALT, FW
    BLACKWELL, TK
    YANCOPOULOS, GD
    [J]. SCIENCE, 1987, 238 (4830) : 1079 - 1087
  • [2] BRUTON TYROSINE KINASE IS TYROSINE-PHOSPHORYLATED AND ACTIVATED IN PRE-B LYMPHOCYTES AND RECEPTOR-LIGATED B-CELLS
    AOKI, Y
    ISSELBACHER, KJ
    PILLAI, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (22) : 10606 - 10609
  • [3] BRUTON OC, 1952, PEDIATRICS, V9, P722
  • [4] CAMPANA D, 1990, J IMMUNOL, V145, P1675
  • [5] EXPRESSION OF THE GENE DEFECT IN X-LINKED AGAMMAGLOBULINEMIA
    CONLEY, ME
    BROWN, P
    PICKARD, AR
    BUCKLEY, RH
    MILLER, DS
    RASKIND, WH
    SINGER, JW
    FIALKOW, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (09) : 564 - 567
  • [6] CONLEY ME, 1985, J IMMUNOL, V134, P3070
  • [7] X-LINKED AGAMMAGLOBULINEMIA - NEW APPROACHES TO OLD QUESTIONS BASED ON THE IDENTIFICATION OF THE DEFECTIVE GENE
    CONLEY, ME
    PAROLINI, O
    ROHRER, J
    CAMPANA, D
    [J]. IMMUNOLOGICAL REVIEWS, 1994, 138 : 5 - 21
  • [8] DISTINCT MOUSE BONE-MARROW MACROPHAGE PRECURSORS IDENTIFIED BY DIFFERENTIAL EXPRESSION OF ER-MP12 AND ER-MP20 ANTIGENS
    DEBRUIJN, MFTR
    SLIEKER, WAT
    VANDERLOO, JCM
    VOERMAN, JSA
    VANEWIJK, W
    LEENEN, PJM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) : 2279 - 2284
  • [9] MUTATION ANALYSIS OF THE BRUTONS TYROSINE KINASE GENE IN X-LINKED AGAMMAGLOBULINEMIA - IDENTIFICATION OF A MUTATION WHICH AFFECTS THE SAME CODON AS IS ALTERED IN IMMUNODEFICIENT XID MICE
    DEWEERS, M
    MENSINK, RGJ
    KRAAKMAN, MEM
    SCHUURMAN, RKB
    HENDRIKS, RW
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (01) : 161 - 166
  • [10] DEWEERS M, 1994, J BIOL CHEM, V269, P23857